Spectral AI’s (MDAI) Sell (D-) Rating Reiterated at Weiss Ratings

Spectral AI (NASDAQ:MDAI)‘s stock had its “sell (d-)” rating reissued by analysts at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen downgraded Spectral AI from a “hold” rating to a “strong sell” rating in a research note on Saturday, August 16th. One analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $3.50.

Spectral AI Stock Up 6.3%

NASDAQ MDAI opened at $2.53 on Wednesday. The stock’s 50-day moving average price is $2.16 and its 200-day moving average price is $1.91. Spectral AI has a 52 week low of $1.01 and a 52 week high of $3.25. The company has a market capitalization of $67.63 million, a P/E ratio of -3.67 and a beta of 0.92.

Spectral AI (NASDAQ:MDAI) last posted its quarterly earnings data on Tuesday, August 12th. The company reported ($0.10) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.03). The firm had revenue of $5.07 million during the quarter, compared to analysts’ expectations of $5.44 million. Spectral AI has set its FY 2025 guidance at EPS. Research analysts anticipate that Spectral AI will post -0.48 EPS for the current year.

Institutional Trading of Spectral AI

Large investors have recently added to or reduced their stakes in the company. Geode Capital Management LLC boosted its holdings in shares of Spectral AI by 21.8% in the 2nd quarter. Geode Capital Management LLC now owns 152,958 shares of the company’s stock worth $379,000 after purchasing an additional 27,365 shares during the period. XTX Topco Ltd purchased a new position in shares of Spectral AI in the 2nd quarter worth approximately $123,000. DNB Asset Management AS purchased a new position in shares of Spectral AI in the 2nd quarter worth approximately $107,000. Marshall Wace LLP purchased a new position in shares of Spectral AI in the 2nd quarter worth approximately $104,000. Finally, Jane Street Group LLC purchased a new position in shares of Spectral AI in the 2nd quarter worth approximately $74,000. Institutional investors own 67.08% of the company’s stock.

Spectral AI Company Profile

Spectral AI, Inc, an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers.